[1] |
Bağcı IS, Horváth ON, Ruzicka T, et al. Bullous pemphigoid[J]. Autoimmun Rev, 2017,16(5):445⁃455. doi: 10.1016/j.autrev.2017. 03.010.
|
[2] |
Lin L, Hwang BJ, Culton DA, et al. Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid[J]. J Invest Dermatol, 2018,138(5):1032⁃1043. doi: 10.1016/j.jid. 2017.11.031.
|
[3] |
Kridin K. Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation[J]. Br J Dermatol, 2018,179(5):1141⁃1147. doi: 10.1111/bjd.16679.
|
[4] |
Zone JJ, Taylor T, Hull C, et al. IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice[J]. J Invest Dermatol, 2007,127(5):1167⁃1174. doi: 10.1038/sj.jid.5700681.
|
[5] |
Rüdrich U, Gehring M, Papakonstantinou E, et al. Eosinophils are a major source of interleukin⁃31 in bullous pemphigoid[J]. Acta Derm Venereol, 2018,98(8):766⁃771. doi: 10.2340/000155 55⁃2951.
|
[6] |
Simon D, Borradori L, Simon HU. Eosinophils as putative therapeutic targets in bullous pemphigoid[J]. Exp Dermatol, 2017,26(12):1187⁃1192. doi: 10.1111/exd.13416.
|
[7] |
Giusti D, Gatouillat G, Le Jan S, et al. Eosinophil cationic protein (ECP), a predictive marker of bullous pemphigoid severity and outcome[J]. Sci Rep, 2017,7(1):4833. doi: 10. 1038/s41598⁃017⁃04687⁃5.
|
[8] |
Caproni M, Palleschi GM, Falcos D, et al. Serum eosinophil cationic protein (ECP) in bullous pemphigoid[J]. Int J Dermatol, 1995,34(3):177⁃180. doi: 10.1111/j.1365⁃4362.1995.tb01562.x.
|
[9] |
Amber KT, Chernyavsky A, Agnoletti AF, et al. Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil⁃derived neurotoxin on human keratinocytes[J]. Exp Dermatol, 2018,27(12):1322⁃1327. doi: 10.1111/exd.13782.
|
[10] |
Tsuda S, Miyasato M, Iryo K, et al. Eosinophil phenotypes in bullous pemphigoid[J]. J Dermatol, 1992,19(5):270⁃279. doi: 10.1111/j.1346⁃8138.1992.tb03224.x.
|
[11] |
Venge P, Byström J, Carlson M, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease[J]. Clin Exp Allergy, 1999,29(9):1172⁃1186. doi: 10.1046/j.1365⁃2222. 1999.00542.x.
|
[12] |
沈佳, 元慧杰, 潘萌. 嗜酸性粒细胞在大疱性类天疱疮发病机制中的作用[J]. 中华皮肤科杂志, 2019,52(8):579⁃581. doi: 10.3760/cma.j.issn.0412⁃4030.2019.08.017.
|
[13] |
Plager DA, Davis MD, Andrews AG, et al. Eosinophil ribonucleases and their cutaneous lesion⁃forming activity[J]. J Immunol, 2009,183(6):4013⁃4020. doi: 10.4049/jimmunol.090 0055.
|